Literature DB >> 11790307

Hus1 acts upstream of chk1 in a mammalian DNA damage response pathway.

Robert S Weiss1, Shuhei Matsuoka, Stephen J Elledge, Philip Leder.   

Abstract

The evolutionarily conserved Hus1 proteins function in DNA damage response pathways that serve to maintain genomic stability. Cells lacking mouse Hus1 are hypersensitive to certain genotoxins, and we have explored the molecular basis for this defect by examining how Hus1 inactivation affects genotoxin-induced signaling events. p53 accumulation and activation in response to DNA damage appeared normal in Hus1 null cells. Likewise, Hus1 was dispensable for genotoxin-induced Chk2 phosphorylation. In contrast, Chk1 phosphorylation after genotoxic stress was greatly reduced in the absence of Hus1, but was restored in Hus1 null fibroblasts complemented by infection with a Hus1-expressing retrovirus. These results demonstrate that mouse Hus1 is required for a specific subset of DNA damage signaling events and functions to promote genotoxin-induced Chk1 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790307     DOI: 10.1016/s0960-9822(01)00626-1

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  31 in total

1.  Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression.

Authors:  Asa Karlsson; Debabrita Deb-Basu; Athena Cherry; Stephanie Turner; James Ford; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

2.  Increased common fragile site expression, cell proliferation defects, and apoptosis following conditional inactivation of mouse Hus1 in primary cultured cells.

Authors:  Min Zhu; Robert S Weiss
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

3.  Specific role of Chk1 phosphorylations in cell survival and checkpoint activation.

Authors:  Hiroyuki Niida; Yuko Katsuno; Birendranath Banerjee; M Prakash Hande; Makoto Nakanishi
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

4.  Genome maintenance defects in cultured cells and mice following partial inactivation of the essential cell cycle checkpoint gene Hus1.

Authors:  Peter S Levitt; Min Zhu; Amy Cassano; Stephanie A Yazinski; Houchun Liu; Joshua Darfler; Rachel M Peters; Robert S Weiss
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

Review 5.  Integrating S-phase checkpoint signaling with trans-lesion synthesis of bulky DNA adducts.

Authors:  Laura R Barkley; Haruo Ohmori; Cyrus Vaziri
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

6.  Coordination of MYH DNA glycosylase and APE1 endonuclease activities via physical interactions.

Authors:  Paz J Luncsford; Brittney A Manvilla; Dimeka N Patterson; Shuja S Malik; Jin Jin; Bor-Jang Hwang; Randall Gunther; Snigdha Kalvakolanu; Leonora J Lipinski; Weirong Yuan; Wuyuan Lu; Alexander C Drohat; A-Lien Lu; Eric A Toth
Journal:  DNA Repair (Amst)       Date:  2013-10-24

7.  Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins.

Authors:  C L Meyerkord; Y Takahashi; R Araya; N Takada; R S Weiss; H-G Wang
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

8.  Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo.

Authors:  Maoyi Lai; Erik S Zimmerman; Vicente Planelles; Junjie Chen
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

9.  HUS1 regulates in vivo responses to genotoxic chemotherapies.

Authors:  G Balmus; P X Lim; A Oswald; K R Hume; A Cassano; J Pierre; A Hill; W Huang; A August; T Stokol; T Southard; R S Weiss
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

10.  Alterations of Chk1 and Chk2 expression in colon cancer.

Authors:  Magdalena Stawinska; Adam Cygankiewicz; Radzislaw Trzcinski; Michal Mik; Adam Dziki; Wanda M Krajewska
Journal:  Int J Colorectal Dis       Date:  2008-08-05       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.